Carcinoembryonic antigen (CEA) is a glycoprotein, and the serum CEA concentration in patients with colon cancer, breast cancer, and lung cancer is significantly higher than that in healthy individuals. Here, CEACAM5 is linked to malignant colon neoplasm.